March 30 (Reuters) - Corline Biomedical AB CLBIO.ST :
* CORLINE BIOMEDICAL AB HAS COMPLETED THE PATIENT
RECRUITMENT IN
THE PHASE 1 STUDY
* CORLINE BIOMEDICAL AB HAS COMPLETED PATIENT RECRUITMENT
IN THE
ONGOING STUDY RENAPAIR-01, IN WHICH CO'S DRUG CANDIDATE
RENAPARIN® IS EVALUATED FOR SAFETY IN ADMINISTRATION IN
CONNECTION WITH KIDNEY TRANSPLANTATION
* AS A RESULT OF ONGOING COVID-19 PANDEMIC, CO HAS DECIDED
TO
COMPLETE RECRUITMENT IN RENAPAIR-01 WITH AROUND 90% OF INITIALLY
PLANNED PATIENT POPULATION
Source text for Eikon: ID:nGNE1Bgghj
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))